Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma

• MORITO Toshiaki

  Department of Pathology, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences

• FUJIHARA Megumu

  Department of Pathology, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital

• ASAOKU Hideki

  Department of Internal Medicine, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital

• TARI Akira

  Department of Internal Medicine, Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital

• SATO Yasuharu

  Department of Pathology, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences

• ICHIMURA Kouichi

  Department of Pathology, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences

• TANAKA Takehiro

  Department of Pathology, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences

• TAKATA Katsuyoshi

  Department of Pathology, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences

• TAMURA Maiko

  Department of Pathology, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences

• YOSHINO Tadashi

  Department of Pathology, Okayama University Graduate School of Medical, Dentistry and Pharmaceutical Sciences

Journal

• Cancer Sci

  Cancer Sci 100 (7), 1255-1260, 2009-07-10

Details

• CRID: 1573950400954195712
• NII Article ID: 10027192146
• NII Book ID: AA11808050
• ISSN: 13479032
• Web Site: https://search.jamas.or.jp/link/ui/2010027163
• Text Lang: en
• Data Source:
  • CiNii Articles